20 employees
Palamedrix leverages DNA nanotechnology for advancements in life science and medicine.
2020
$6M
from 2 investors over 2 rounds
Palamedrix raised $6M on March 1, 2021
Investors: Casdin Capital, LLC and FoundersX Ventures